117 related articles for article (PubMed ID: 37356938)
1. [Expression of
Wang YR; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):769-776. PubMed ID: 37356938
[TBL] [Abstract][Full Text] [Related]
2. [Expression and Clinical Significance of NAMPT in Bone Marrow of Patients with Multiple Myeloma].
Wang YR; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1739-1744. PubMed ID: 38071054
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism and Clinical Significance of
Wang YR; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):138-145. PubMed ID: 38387912
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].
Wang XX; Zhang LL; Wang T; Hou JX; Wang ZT; Qin H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):777-782. PubMed ID: 37356939
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China.
Wang H; Meng H; Wang J; Lou Y; Zhou Y; Lin P; Li F; Liu L; Xu H; Yang M; Jin J
Front Med; 2020 Jun; 14(3):327-334. PubMed ID: 31784918
[TBL] [Abstract][Full Text] [Related]
6. High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.
Fan L; Hong J; Huang H; Fu D; Wu S; Wang Q; Ye Y; Liu Y
Med Sci Monit; 2017 May; 23():2636-2643. PubMed ID: 28557972
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of survivin in bone marrow cells of multiple myeloma patients].
Li J; Zhao Y; Zhang DB; Huang BH
Ai Zheng; 2005 Dec; 24(12):1522-6. PubMed ID: 16351806
[TBL] [Abstract][Full Text] [Related]
8. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract][Full Text] [Related]
9. Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
Terpos E; Katodritou E; Tsiftsakis E; Kastritis E; Christoulas D; Pouli A; Michalis E; Verrou E; Anargyrou K; Tsionos K; Dimopoulos MA; Zervas K;
Haematologica; 2009 Mar; 94(3):372-9. PubMed ID: 19252175
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma.
Davis K; Dunseth CD; Mott SL; Cramer-Morales KL; Miller AM; Ear PH; Mezhir JJ; Bellizzi AM; Chan CHF
PLoS One; 2019; 14(3):e0213576. PubMed ID: 30856230
[TBL] [Abstract][Full Text] [Related]
11. [Expression and Clinical Significance of C/EBPα Gene in Elderly Multiple Myeloma].
Zang YZ; Chen XL; Bai YL; Zhang WH; Yu RH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):123-128. PubMed ID: 30738458
[TBL] [Abstract][Full Text] [Related]
12. Identification and expression of MMSA-8, and its clinical significance in multiple myeloma.
He R; Yang N; Zhang P; Liu J; Li J; Zhou F; Zhang W
Oncol Rep; 2017 Jun; 37(6):3235-3243. PubMed ID: 28498418
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients].
Liu XL; Yang PY; Yu XY; Chen JC; Liu XL; Bai J; Liu YM; He H; Sun JN; Fan HQ; Zhang C; Zhang Y; Su KJ; Liu CS; Tan YH; Gao SJ; Li W; Jin FY
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):408-413. PubMed ID: 29779352
[No Abstract] [Full Text] [Related]
14. [Expression of SIL-2R in Patients with Multiple Myeloma and Its Clinical Significance].
Lin P; Lin XR; Liu QL; Zhang XY; Chen GW; Xie RT; Zhang YL; DU XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1797-1802. PubMed ID: 36476906
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the clinical effects and outcome of patients with double-hit high-risk multiple myeloma].
Liu S; Shang J; Lin Y; Wang ZH; Wei TN; Lin L; Yang T; Chen WM
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1209-1214. PubMed ID: 34794226
[No Abstract] [Full Text] [Related]
16. Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy.
Bobbert P; Kühl U; Poller W; Rauch U; Schultheiss HP; Skurk C
J Card Fail; 2015 Apr; 21(4):330-8. PubMed ID: 25498756
[TBL] [Abstract][Full Text] [Related]
17. MMSA-1 expression pattern in multiple myeloma and its clinical significance.
Meng S; Lu C; Zhang W; Shen W; Wei Y; Su D; Zhou F
Clin Exp Med; 2016 Nov; 16(4):599-609. PubMed ID: 26493349
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of beta-catenin in multiple myeloma].
Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Significance of CD28 Expression in Newly Diagnosed Multiple Myeloma].
Zhang PP; Li JJ; Hu ZL; Zhu JF; Wang M; Zhang F; Li BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1785-1790. PubMed ID: 36476904
[TBL] [Abstract][Full Text] [Related]
20. Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.
Wang W; Xie Y; Han X; Liu Y; Li P
Technol Cancer Res Treat; 2020; 19():1533033820935856. PubMed ID: 32799782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
